2AK-21023-19205 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2020-12-21
Dose 1 — Pfizer-BioNTech
2021-01-08
Dose 2 — Pfizer-BioNTech
2021-06-11
Registered in v-safe
2021-07-10
Health check-in — 6 months, dose 2
Feeling: Good

Adult check-in
2021-09-25
Dose 3 — Pfizer-BioNTech
Co-administered: Flu
2021-09-29
Health check-in — days 1–6 daily, dose 3
Feeling: Good · Site: Redness, Itching · None

Adult check-in
2021-09-30
Health check-in — days 1–6 daily, dose 3
Feeling: Good · None

Adult check-in
2021-10-01
Health check-in — days 1–6 daily, dose 3
Feeling: Good · None

Adult check-in
2021-10-02
Health check-in — day 7, dose 3
Feeling: Good · None

Adult check-in
2021-10-09
Health check-in — day 14, dose 3
Feeling: Good

Adult check-in
2021-10-16
Health check-in — day 21, dose 3
Feeling: Good

Adult check-in
2021-10-23
Survey response — day 28, dose 3
MedDRA: Cough, Pyrexia, Rhinorrhoea, Viral infection — Feeling: Good

Free text: Acquired viral infection from child earlier in the week. Low grade fever, running nose, and cough.

MedDRA releases: 2024-11 · check-in free text available
2021-10-30
Survey response — day 35, dose 3
MedDRA: Viral infection — Feeling: Good · Be unable to work or attend school

Free text: Viral infection that was not COVID.

MedDRA releases: 2024-11 · check-in free text available
2021-11-06
Health check-in — day 42, dose 3
Feeling: Good

Adult check-in
2021-12-25
Health check-in — 3 months, dose 3
Feeling: Fair

Adult check-in
2022-03-26
Survey response — 6 months, dose 3
MedDRA: Adverse reaction, Ear infection — Feeling: Poor · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation

Free text: Ear infection, seasonal allergy symptoms

MedDRA releases: 2024-11 · check-in free text available
2022-03-26
Report sent to call center — 6 months, dose 3
Get care from a doctor or other healthcare professional

Telehealth, virtual health, or email health consultation · 1 call case(s)
2022-03-28
Call 1 — Left Voicemail
2022-09-25
Survey response — 12 months, dose 3
MedDRA: COVID-19, Pregnancy — Feeling: Good · Be unable to work or attend school

Free text: COVID infection, pregnancy

MedDRA releases: 2024-11 · check-in free text available

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2020-12-21	Pfizer-BioNTech
2	2021-01-08	Pfizer-BioNTech
3	2021-09-25	Pfizer-BioNTech	Flu

Call center

Reported	Outcome	VAERS-related outcome
2022-03-26	Unsuccessful

Free text

Release 10 — day 28, dose 3

2021-10-23

Symptoms: Acquired viral infection from child earlier in the week. Low grade fever, running nose, and cough.

Release 10 — day 35, dose 3

2021-10-30

Symptoms: Viral infection that was not COVID.

Release 11 — 6 months, dose 3

2022-03-26

Symptoms: Ear infection, seasonal allergy symptoms

Release 12 — 12 months, dose 3

2022-09-25

Symptoms: COVID infection, pregnancy

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Adverse reaction	·	·	✓
SD	Cough	·	·	✓
SD	COVID-19	·	·	✓
SD	Ear infection	·	·	✓
SD	Pregnancy	·	·	✓
SD	Pyrexia	·	·	✓
SD	Rhinorrhoea	·	·	✓
SD	Viral infection	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release